1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: A randomized phase I trial
    Journal Article

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H. A.; Pesci, G.; Kim, H.; Chino, J. P.; Banbury, B.; Sherry, N.; Sharon, E.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): Results from a randomised, open-label, phase 3 trial
    Journal Article

    Mina, R.; Mylin, A. K.; Yokoyama, H.; Magen, H.; Alsdorf, W.; Minnema, M. C.; Shune, L.; Isufi, I.; Harrison, S. J.; Shah, U. A.; more...
    The Lancet Haematology (2025)

    Fulltext@MSK | Save
  • Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): A multiregional, randomised, double-blind, placebo-controlled, phase 3 study
    Journal Article

    Sangro, B.; Kudo, M.; Erinjeri, J. P.; Qin, S.; Ren, Z.; Chan, S. L.; Arai, Y.; Heo, J.; Mai, A.; Escobar, J.; more...
    Lancet (2025)

    Fulltext@MSK | Save
  • Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: Whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery
    Journal Article

    Ganz, P. A.; Cecchini, R. S.; White, J. R.; Vicini, F. A.; Arthur, D. W.; Rabinovitch, R. A.; Kuske, R. R.; Julian, T. B.; Parda, D. S.; Scheier, M. F.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • Imaging in diagnosis and active surveillance for prostate cancer: A review
    Review

    Li, T.; Nalavenkata, S.; Fainberg, J.
    JAMA Surgery (2025)

    Fulltext@MSK | Save
  • Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: The phase II FRACTION gastric cancer study
    Journal Article

    Ku, G.; Haag, G. M.; Park, H.; Lam, V. K.; George, T. J.; Kim, S. S.; Gutierrez, M.; Shankaran, V.; Stein, S.; Denlinger, C. S.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Feasibility and preliminary effects of acupuncture for cognitive dysfunction in diverse cancer survivors: A pilot, randomized, placebo-controlled trial
    Journal Article

    Li, X.; Lampson, K.; Ahles, T. A.; Root, J. C.; Li, Q. S.; Li, Y.; Ahsan, A.; Mao, J. J.; Liou, K. T.
    Current Oncology (2025)

    Fulltext@MSK | Save
  • Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance
    Journal Article

    Ganti, A. K.; Fruth, B.; Rimner, A.; Waqar, S.; Mix, M. D.; Petty, W. J.; Stinchcombe, T. E.; Vokes, E. E.; Bogart, J. A.; Dueck, A. C.
    Cancer (2025)

    Fulltext@MSK | Save
  • Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912
    Research Letter

    Shanafelt, T. D.; Wang, X. V.; Hanson, C. A.; Paietta, E.; O’Brien, S.; Barrientos, J.; Jelinek, D. F.; Braggio, E.; Leis, J. F.; Zhang, C. C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Multimodal treatment of resectable esophageal cancer
    Review

    Waters, J.; Sewell, M.; Molena, D.
    Annals of Thoracic Surgery (2025)

    Fulltext@MSK | Save